Company Comparison
KSQ Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | KSQ Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | South San Francisco, California |
| Founded | 2018 | 2006 |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $63M | — |
| Valuation | — | — |
What They Build
KSQ Therapeutics
A biotechnology company developing cancer immunotherapies using CRISPR-based functional genomics to identify novel drug targets.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
KSQ Therapeutics
Sector Overlap
Both KSQ Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.